24 Facts About Roche


Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics.

FactSnippet No. 1,469,353

Roche is the fifth largest pharmaceutical company in the world by revenue, and the leading provider of cancer treatments globally.

FactSnippet No. 1,469,354

Roche is one of the few companies increasing their dividend every year, for 2020 as the 34th consecutive year.

FactSnippet No. 1,469,355

Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations .

FactSnippet No. 1,469,356

That year Hoffmann-La Roche then merged it with all of its laboratories, and incorporated the merged company as Roche Biomedical Laboratories, Inc in Burlington.

FactSnippet No. 1,469,357

Roche acquired Syntex in 1994 and Chugai Pharmaceuticals in 2002.

FactSnippet No. 1,469,358

Roche is the only drug company authorized to manufacture the drug, which was discovered by Gilead Sciences.

FactSnippet No. 1,469,359

On 20 October 2005 Hoffmann-La Roche decided to license other companies to manufacture Oseltamivir.

FactSnippet No. 1,469,360

Also in 2005 Roche acquired the Swiss company GlycArt Biotechnology in order to acquire technology to afucosylate antibodies; one of its products in development was obinutuzumab, which gained FDA approval in November 2013 for the treatment of chronic lymphocytic leukemia.

FactSnippet No. 1,469,361

On 12 March 2009 Roche agreed to fully acquire Genentech, in which it had held a majority stake since 1990, after eight months of negotiations.

FactSnippet No. 1,469,362

Roche began vacating the NJ site in 2012, and sold it off in 2016.

FactSnippet No. 1,469,363

In March 2011, Roche acquired PVT Probenverteiltechnik GmbH for up to €85 million.

FactSnippet No. 1,469,364

In July 2010, Roche acquired mtm laboratories AG for up to 190 million EUR.

FactSnippet No. 1,469,365

In July 2013, Roche Diagnostics acquired blood diagnostics company Constitution Medical Inc for $220 million.

FactSnippet No. 1,469,366

On 7 April 2014, Roche announced its intention to acquire IQuum for up to $450 million, as well as the rights to an experimental drug from Spanish company Oryzon Genomics for $21 million and up to $500 million in milestone payments.

FactSnippet No. 1,469,367

In February 2018, Roche announced it would acquire Flatiron Health, a business specialising in US cancer data analytics, for $1.

FactSnippet No. 1,469,368

In March 2021, Roche announced it would acquire GenMark Diagnostics for $1.

FactSnippet No. 1,469,369

Hoffmann-La Roche family is Switzerland's richest and one of the most secretive families.

FactSnippet No. 1,469,370

All business areas except Roche Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers.

FactSnippet No. 1,469,371

Hoffmann-La Roche develops drugs used for cancer treatment, against virus diseases and for treatment of metabolic diseases.

FactSnippet No. 1,469,372

Roche was fined accordingly, but a bungle on the part of the EEC allowed the company to discover that it was Adams who had blown the whistle.

FactSnippet No. 1,469,373

Roche's wife, having learnt that he might face decades in jail, committed suicide.

FactSnippet No. 1,469,374

Hoffmann-La Roche paid $500 million in criminal fines to the United States.

FactSnippet No. 1,469,375

Roche is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.

FactSnippet No. 1,469,376